A study of the effect of different doses of dexamethasone on the duration of an single shot interscalene block for shoulder surgery.
- Conditions
- Postoperative painTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2012-005565-12-BE
- Lead Sponsor
- AZ Groeninge
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
patients >18 years for arthroscopic shoulder surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
Exclusion criteria are: age <18 years, brachial plexus neuropathies, severe bronchopulmonary disease, coagulopathies, systemic glucocorticoid use, pregnancy, intolerance to the study medication and diabetes.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: What is the effect of different doses of intravenous dexamethasone<br>on postoperative analgesia after interscalene plexus block for shoulder surgery.;Secondary Objective: What is the effect of different doses of dexamethasone on postoperative painscores, analgesic use, patient satisfaction, duration and quality of motor block and sleep disturbance.;Primary end point(s): time to first analgesic request;Timepoint(s) of evaluation of this end point: 48h
- Secondary Outcome Measures
Name Time Method Secondary end point(s): pains scores<br>analgesic use<br>motor block scores<br>sleep disturbance<br>patient satisfaction;Timepoint(s) of evaluation of this end point: 48 hours